Company:  NATERA, INC. (NTRA)
Form Type:  10-Q
Filing Date:  8/6/2021 
CIK:  0001604821 
Address:  13011 MCCALLEN PASS
BUILDING A SUITE 100
 
City, State, Zip:  AUSTIN, Texas 78753 
Telephone:  650-249-9090 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$111.39  
Change: 
0.62 (0.56%)  
Trade Time: 
Oct 18  
Market Cap: 
$10.45B
Trade NTRA now with 

© 2021  
Description of Business
We are a diagnostics company with proprietary molecular and bioinformatics technology that we are applying to change the management of disease worldwide. Our cell-free DNA, or cfDNA, technology combines our novel molecular assays, which reliably measure many informative regions across the genome from samples as small as a single cell, with our statistical algorithms which incorporate data available from the broader scientific community to identify genetic variations covering a wide range of serious conditions with best-in-class accuracy and coverage. Our technology has been proven clinically and commercially in the women's health space, in which we develop and commercialize non- or minimally- invasive tests to evaluate risk for, and thereby enable early detection of, a wide range of genetic conditions, such as Down syndrome.
Register and access this filing in:     
  FORM 10-Q
    PART I - FINANCIAL INFORMATION
      ITEM 1. FINANCIAL STATEMENTS
        BALANCE SHEET
        INCOME STATEMENT
        STOCKHOLDERS EQUITY
        STOCKHOLDERS EQUITY
        STOCKHOLDERS EQUITY
        CASH FLOW
        Notes to Unaudited Interim Condensed Consolidated Financial ...
          STOCKHOLDERS EQUITY
          BALANCE SHEET
      ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL ...
      ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT ...
      ITEM 4. CONTROLS AND PROCEDURES
    PART II - OTHER INFORMATION
      ITEM 1.LEGAL PROCEEDINGS
      ITEM 1A.RISK FACTORS
      ITEM 2 UNREGISTERED SALES OF EQUITY SECURITIES AND USE ...
      ITEM 3 DEFAULTS UPON SENIOR SECURITIES
      ITEM 4 MINE SAFETY DISCLOSURES
      ITEM 5 OTHER INFORMATION
      ITEM 6 EXHIBITS
    INDEX TO EXHIBITS
    SIGNATURES
  EXHIBIT 31.1
    CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
  EXHIBIT 31.2
    CERTIFICATION OF PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER
  EXHIBIT 32.1
    CERTIFICATION PURSUANT TO
  EXHIBIT 32.2
    CERTIFICATION PURSUANT TO